Greenwich LifeSciences, Inc. (GLSI) stock
GLSINasdaqPharmaceutical PreparationsFiscal year ends December 31
$18.70+4.94 (+35.90%)
Close on Nov 17, 2026Market cap $274.48MP/E –Yield –
Greenwich LifeSciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Greenwich LifeSciences's price to book ratio was 75.8× on Nov 11, 2026, against 255.9× a year earlier. Over the last 5 years it ranged from 5.1× to 255.9×, with a median of 17.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 75.8× | −56.9 |
| 2025 | Dec 31, 2025 | 132.6× | +103.0 |
| 2024 | Dec 31, 2024 | 29.6× | +14.4 |
| 2023 | Dec 29, 2023 | 15.3× | +2.6 |
| 2022 | Dec 30, 2022 | 12.7× | +1.6 |
| 2021 | Dec 31, 2021 | 11.1× | −82.6 |
| 2020 | Dec 31, 2020 | 93.7× | – |
See a number that looks wrong?